Dec 16, 2020 – Wilmar, MN, USA Vaxxinova US has acquired marketing rights from Zoetis for a vaccine against Salmonella in cattle. Until now, the SRP Salmonella vaccine – the first USDA-licensed vaccine to use SRP technology – was manufactured by Vaxxinova US but marketed by Zoetis. With the latest license acquisition, Vaxxinova US now […]
Dutch farmers Magazine “Boerderij” published an article on autogenous vaccines in its June 16, 2020 edition. The article mentions how autogenous vaccines can contribute to reduced antibiotic use in swine and Vaxxinova’s contribution to this. Read the full article here.
Nijmegen, The Netherlands, Wednesday June 3, 2020. Vaxxinova® Nederland BV is pleased to announce two new directors to its team as per June 1, 2020. Both positions are based in Nijmegen. Mrs. Mirjam van der Sluijs will take up the role of Director R&D Nijmegen. As Director R&D Nijmegen Mirjam will lead the R&D and […]
Nijmegen, The Netherlands, Tuesday June 2, 2020. Vaxxinova® International announces that starting June 1, 2020, Dr. Matias del Campo will be the Managing Director for Vaxxinova Norway and Vaxxinova Chile. Matias will be responsible for the global cold-water aquaculture business. Matias is an Aquaculture Engineer from the University Andres Bello in Chile and holds a […]
Nijmegen, The Netherlands, Wednesday January 22, 2020. Vaxxinova is pleased to announce that last week the USDA granted Epitopix the license for Vaxxon® SRP® SE, a poultry vaccine which has been shown to have an effect against colonization of Salmonella Enteritidis in the reproductive tract. Vaxxon® SRP® SE uses innovative siderophore receptor and porin (SRP) […]
Nijmegen, The Netherlands, Friday January 17, 2020. In January 2020, Vaxxinova will be present at the IPPE 2020 trade show in Atlanta. Our team is ready to meet you at booth C10361. The show is open to visitors on Tue Jan 28 (10 AM – 5 PM), Wed Jan 29 (9AM – 5PM), Thu Jan […]
